1 Min Read
Dec 16 (Reuters) - 4SC AG :
* First patient enrolled in pivotal RESMAIN study of resminostat in CTCL
* Topline data expected in 2019 Source text for Eikon: Further company coverage: (Gdynia Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.